José Lillo-Moya

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Acute Myocardial Infarction

Oxidative Stress

Top Venues

Redox report : communications in free radical research

Antioxidants (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo-Moya, Tommy González-Fernández, Luciano Saso, Ramón Rodrigo
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox report : communications in free radical research 29 (1) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, José Lillo-Moya, Tommy González-Fernández, Joaquin Abelli, Antonia Cereceda-Cornejo, Maria Chiara Bragato, Sarmistha Saha, Ramón Rodrigo
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies. Biomedicines 11 (3) (2023)
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo-Moya, Tommy González-Fernández, Luciano Saso, Ramón Rodrigo
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox report : communications in free radical research 29 (1) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo-Moya, Tommy González-Fernández, Luciano Saso, Ramón Rodrigo
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox report : communications in free radical research 29 (1) (2023)
Catalina Rojas-Solé, Víctor Pinilla-González, José Lillo-Moya, Tommy González-Fernández, Luciano Saso, Ramón Rodrigo
Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox report : communications in free radical research 29 (1) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, José Lillo-Moya, Tommy González-Fernández, Joaquin Abelli, Antonia Cereceda-Cornejo, Maria Chiara Bragato, Sarmistha Saha, Ramón Rodrigo
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies. Biomedicines 11 (3) (2023)
Ramón Rodrigo, Juan Carlos Prieto, Rubén Aguayo, Cristóbal Ramos, Ángel Puentes, Abraham Gajardo, Emiliano Panieri, Catalina Rojas-Solé, José Lillo-Moya, Sarmistha Saha
Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Molecules (Basel, Switzerland) 26 (18) (2021)
José Lillo-Moya, Catalina Rojas-Solé, Diego Muñoz-Salamanca, Emiliano Panieri, Sarmistha Saha, Ramón Rodrigo
Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury. Antioxidants (Basel, Switzerland) 10 (5) (2021)